Nextcure Stock Market Value
| NXTC Stock | USD 1.29 0.01 0.77% |
| Symbol | NextCure |
NextCure Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of NextCure. If investors know NextCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about NextCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.08) | Quarterly Revenue Growth (1.00) | Return On Assets (0.31) | Return On Equity (0.55) |
The market value of NextCure is measured differently than its book value, which is the value of NextCure that is recorded on the company's balance sheet. Investors also form their own opinion of NextCure's value that differs from its market value or its book value, called intrinsic value, which is NextCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because NextCure's market value can be influenced by many factors that don't directly affect NextCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between NextCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if NextCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, NextCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
NextCure 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to NextCure's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of NextCure.
| 05/26/2024 |
| 11/22/2024 |
If you would invest 0.00 in NextCure on May 26, 2024 and sell it all today you would earn a total of 0.00 from holding NextCure or generate 0.0% return on investment in NextCure over 180 days. NextCure is related to or competes with ZyVersa Therapeutics, Sonnet Biotherapeutics, Zura Bio, Phio Pharmaceuticals, Transcode Therapeutics, and Quoin Pharmaceuticals. NextCure, Inc., a clinical-stage biopharmaceutical company, engages in discovering and developing novel immunomedicines ... More
NextCure Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure NextCure's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess NextCure upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.11) | |||
| Maximum Drawdown | 21.68 | |||
| Value At Risk | (5.52) | |||
| Potential Upside | 5.22 |
NextCure Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for NextCure's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as NextCure's standard deviation. In reality, there are many statistical measures that can use NextCure historical prices to predict the future NextCure's volatility.| Risk Adjusted Performance | (0.05) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.70) | |||
| Treynor Ratio | (5.12) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of NextCure's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
NextCure Backtested Returns
NextCure has Sharpe Ratio of -0.0812, which conveys that the firm had a -0.0812% return per unit of risk over the last 3 months. NextCure exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify NextCure's Mean Deviation of 2.55, standard deviation of 3.53, and Risk Adjusted Performance of (0.05) to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 0.0588, which conveys not very significant fluctuations relative to the market. As returns on the market increase, NextCure's returns are expected to increase less than the market. However, during the bear market, the loss of holding NextCure is expected to be smaller as well. At this point, NextCure has a negative expected return of -0.29%. Please make sure to verify NextCure's potential upside, rate of daily change, as well as the relationship between the Rate Of Daily Change and relative strength index , to decide if NextCure performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.15 |
Insignificant reverse predictability
NextCure has insignificant reverse predictability. Overlapping area represents the amount of predictability between NextCure time series from 26th of May 2024 to 24th of August 2024 and 24th of August 2024 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of NextCure price movement. The serial correlation of -0.15 indicates that less than 15.0% of current NextCure price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.15 | |
| Spearman Rank Test | -0.21 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
NextCure lagged returns against current returns
Autocorrelation, which is NextCure stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting NextCure's stock expected returns. We can calculate the autocorrelation of NextCure returns to help us make a trade decision. For example, suppose you find that NextCure has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
NextCure regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If NextCure stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if NextCure stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in NextCure stock over time.
Current vs Lagged Prices |
| Timeline |
NextCure Lagged Returns
When evaluating NextCure's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of NextCure stock have on its future price. NextCure autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, NextCure autocorrelation shows the relationship between NextCure stock current value and its past values and can show if there is a momentum factor associated with investing in NextCure.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether NextCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of NextCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Nextcure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Nextcure Stock:Check out NextCure Correlation, NextCure Volatility and NextCure Alpha and Beta module to complement your research on NextCure. For information on how to trade NextCure Stock refer to our How to Trade NextCure Stock guide.You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
NextCure technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.